Articles with public access mandates - Zheng Siyuan, Ph.D.Learn more
Not available anywhere: 1
Molecular profiling of long-term survivors identifies a subgroup of glioblastoma characterized by chromosome 19/20 co-gain
C Geisenberger, A Mock, R Warta, C Rapp, C Schwager, A Korshunov, ...
Acta neuropathologica 130, 419-434, 2015
Mandates: US National Institutes of Health
Available somewhere: 80
The somatic genomic landscape of glioblastoma
CW Brennan, RGW Verhaak, A McKenna, B Campos, H Noushmehr, ...
cell 155 (2), 462-477, 2013
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma
M Ceccarelli, FP Barthel, TM Malta, TS Sabedot, SR Salama, BA Murray, ...
Cell 164 (3), 550-563, 2016
Mandates: US National Institutes of Health
Comprehensive and integrative genomic characterization of hepatocellular carcinoma
A Ally, M Balasundaram, R Carlsen, E Chuah, A Clarke, N Dhalla, RA Holt, ...
Cell 169 (7), 1327-1341. e23, 2017
Mandates: US National Institutes of Health, US Department of Veterans Affairs
Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment
Q Wang, B Hu, X Hu, H Kim, M Squatrito, L Scarpace, AC DeCarvalho, ...
Cancer cell 32 (1), 42-56. e6, 2017
Mandates: US National Institutes of Health
Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin
KA Hoadley, C Yau, DM Wolf, AD Cherniack, D Tamborero, S Ng, ...
Cell 158 (4), 929-944, 2014
Mandates: US National Institutes of Health
Integrative genomic analysis of cholangiocarcinoma identifies distinct IDH-mutant molecular profiles
F Farshidfar, S Zheng, MC Gingras, Y Newton, J Shih, AG Robertson, ...
Cell reports 18 (11), 2780-2794, 2017
Mandates: US National Institutes of Health
Comprehensive pan-genomic characterization of adrenocortical carcinoma
S Zheng, AD Cherniack, N Dewal, RA Moffitt, L Danilova, BA Murray, ...
Cancer cell 29 (5), 723-736, 2016
Mandates: US National Institutes of Health
Systematic analysis of telomere length and somatic alterations in 31 cancer types
FP Barthel, W Wei, M Tang, E Martinez-Ledesma, X Hu, SB Amin, ...
Nature genetics 49 (3), 349-357, 2017
Mandates: US National Institutes of Health
Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution
H Kim, S Zheng, SS Amini, SM Virk, T Mikkelsen, DJ Brat, J Grimsby, ...
Genome research 25 (3), 316-327, 2015
Mandates: US National Institutes of Health
The landscape and therapeutic relevance of cancer-associated transcript fusions
K Yoshihara, Q Wang, W Torres-Garcia, S Zheng, R Vegesna, H Kim, ...
Oncogene 34 (37), 4845-4854, 2015
Mandates: US National Institutes of Health
Hdac3 is essential for the maintenance of chromatin structure and genome stability
S Bhaskara, SK Knutson, G Jiang, MB Chandrasekharan, AJ Wilson, ...
Cancer cell 18 (5), 436-447, 2010
Mandates: US National Institutes of Health
dmGWAS: dense module searching for genome-wide association studies in protein–protein interaction networks
P Jia, S Zheng, J Long, W Zheng, Z Zhao
Bioinformatics 27 (1), 95-102, 2011
Mandates: US National Institutes of Health
Discordant inheritance of chromosomal and extrachromosomal DNA elements contributes to dynamic disease evolution in glioblastoma
AC Decarvalho, H Kim, LM Poisson, ME Winn, C Mueller, D Cherba, ...
Nature genetics 50 (5), 708-717, 2018
Mandates: US National Institutes of Health, Genome Canada
TumorFusions: an integrative resource for cancer-associated transcript fusions
X Hu, Q Wang, M Tang, F Barthel, S Amin, K Yoshihara, FM Lang, ...
Nucleic acids research 46 (D1), D1144-D1149, 2018
Mandates: US National Institutes of Health
PRADA: pipeline for RNA sequencing data analysis
W Torres-García, S Zheng, A Sivachenko, R Vegesna, Q Wang, R Yao, ...
Bioinformatics 30 (15), 2224-2226, 2014
Mandates: US National Institutes of Health
Genomic profiling of childhood tumor patient-derived xenograft models to enable rational clinical trial design
JL Rokita, KS Rathi, MF Cardenas, KA Upton, J Jayaseelan, KL Cross, ...
Cell reports 29 (6), 1675-1689. e9, 2019
Mandates: US National Institutes of Health, National Health and Medical Research …
ZFHX4 interacts with the NuRD core member CHD4 and regulates the glioblastoma tumor-initiating cell state
Y Chudnovsky, D Kim, S Zheng, WA Whyte, M Bansal, MA Bray, S Gopal, ...
Cell reports 6 (2), 313-324, 2014
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
The Pan-Cancer analysis of pseudogene expression reveals biologically and clinically relevant tumour subtypes
L Han, Y Yuan, S Zheng, Y Yang, J Li, ME Edgerton, L Diao, Y Xu, ...
Nature communications 5 (1), 3963, 2014
Mandates: US National Institutes of Health
A high Notch pathway activation predicts response to γ secretase inhibitors in proneural subtype of glioma tumor-initiating cells
N Saito, J Fu, S Zheng, J Yao, S Wang, DD Liu, Y Yuan, EP Sulman, ...
Stem cells 32 (1), 301-312, 2014
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program